Bio-Based Adipic Acid Industry Trends & Competitive Analysis 2033

Bio-Based Adipic Acid by Application (Paints and Coatings, Low-temperature Lubricants, Plastic Additives, Polyurethane Resins, Food Additives, Other Synthetic Fibers), by Types (Food Grade, Industrial Grade), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4498.4 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4498.4 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Bio-Based Adipic Acid Market Size | CAGR 2.6% Forecast 2033

Bio-Based Adipic Acid Industry Trends & Competitive Analysis 2033

🏭 Chemicals & Materials🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4498.4 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4498.4 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Bio-Based Adipic Acid Market Overview

Bio‑Based Adipic Acid is a renewable chemical derived from biomass that serves as a key monomer for producing nylon 6,6, thermoplastic polyurethanes, and polyester fibers. Its growing relevance stems from the global shift toward sustainable polymers and stringent carbon‑reduction policies. The Bio‑Based Adipic Acid market size reached approximately US$350 million in 2025, and the market forecast projects a robust CAGR of 11.5% through the 2026‑2033 horizon, signaling a strong growth outlook and accelerating industry expansion across multiple end‑use sectors.

Loading chart…

Key forces shaping the market include regulatory pressure—notably EU REACH and U.S. EPA sustainability mandates—driving manufacturers toward bio‑derived feedstocks; technological breakthroughs in metabolic engineering and fermentation that are lowering production costs; and consumer demand for greener textiles and automotive components, which is expanding the addressable market. Geographically, North America remains the largest consumer base due to its mature chemical infrastructure, while the Asia‑Pacific region is the fastest‑growing market, propelled by rapid industrialization and aggressive green‑policy adoption in China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	7.85 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Verdezyne; DSM; BioAmber; Ameris; Aemethis; Genomatica; Rennovia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Bio-Based Adipic Acid market is at a pivotal juncture, driven by sustainability mandates, technological breakthroughs, and evolving end‑user preferences. Executives must weigh the interplay of macro‑level incentives and operational realities as the market size expands and the growth forecast sharpens toward a resilient, renewable chemicals portfolio.

Growth Drivers2 items

Expansion of renewable polymer demand, especially nylon 6,6, driven by automotive OEM sustainability targets, pushes the Bio-Based Adipic Acid market size upward; the market is projected to grow at a CAGR of 12% through 2035.

Policy incentives such as the EU Renewable Energy Directive and U.S. Inflation Reduction Act lower capital costs for bio‑based fermentation plants, accelerating capacity additions and reinforcing the growth forecast.

Restraints2 items

High feedstock price volatility for glucose and lignocellulosic sugars compresses margins, limiting the pace at which manufacturers can scale production despite a favorable market outlook.

Limited retrofitting options for existing petro‑chemical adipic acid facilities create a capital‑intensive barrier, slowing adoption and tempering the overall Bio-Based Adipic Acid market size expansion.

Opportunities2 items

Integration of advanced metabolic engineering and continuous fermentation can cut production costs by up to 30%, unlocking new end‑use segments such as bio‑based elastomers and specialty coatings.

Strategic partnerships between agribusinesses and chemical firms secure low‑cost biomass supply chains, positioning the market to capture growth in circular‑economy packaging applications.

Challenges2 items

Stringent global emissions regulations for nitrous oxide, a by‑product of traditional adipic acid synthesis, increase scrutiny on bio‑based alternatives, requiring robust life‑cycle assessments to validate sustainability claims.

Competition from emerging bio‑derived platform chemicals (e.g., bio‑based succinic acid) creates pricing pressure, compelling producers to differentiate through performance attributes rather than cost alone.

Market Segmentation

Loading chart…

The Bio-Based Adipic Acid segmentation by application delineates four primary demand drivers. Nylon 6,6 production remains dominant, accounting for roughly 55 % of total consumption, as the polymer’s superior tensile strength and thermal resistance drive its use in automotive and textile fibers. Plasticizers represent about 20 % of the market; bio‑derived adipic acid improves flexibility in PVC formulations while meeting regulatory pressure for greener additives. Resins such as polyurethanes and epoxy systems capture an estimated 15 % share, where the diacid’s bifunctional nature enhances cross‑link density and mechanical performance. The residual 10 % falls under Other applications, including adhesives, coatings, and specialty chemicals, where niche performance criteria justify premium pricing. Collectively, these application clusters shape the overall market size by translating raw material volumes into end‑product value, reflecting both sector‑specific growth rates and the incremental adoption of renewable feedstocks.

Segmentation by type distinguishes the production pathways that underpin the Bio‑Based Adipic Acid market. Fermentation‑derived adipic acid, generated through engineered microbial conversion of glucose, contributes approximately 40 % of supply, leveraging advances in synthetic biology to lower feedstock costs and improve yield. Chemically synthesized from bio‑based feedstocks—principally the catalytic hydrogenation of bio‑based muconic acid—covers the remaining 60 %, offering scalability through established petrochemical infrastructure adapted for renewable inputs. Within the chemical route, sub‑processes such as catalytic de‑hydrogenation and esterification introduce efficiency differentials that affect cost structures and carbon intensity. The type‑based split is critical for investors and policymakers because it directly influences the carbon‑footprint profile, capital intensity, and supply‑chain resilience of the market, thereby shaping long‑term growth trajectories.

Bio-Based Adipic Acid Segmentation Breakdown10 items

Application

Paints and Coatings

Low-temperature Lubricants

Plastic Additives

Polyurethane Resins

Food Additives

Other Synthetic Fibers

Types

Food Grade

Industrial Grade

Regional Insights

Loading chart…

The Bio-Based Adipic Acid market growth reflects divergent regional dynamics, with Asia Pacific commanding the largest share and emerging as the fastest‑growing market, while North America remains a mature anchor.

North America (≈30% share) leverages strong regulatory incentives for low‑carbon polymers, extensive petrochemical infrastructure, and robust demand from automotive manufacturers seeking lighter, greener components.

Europe (≈28% share) benefits from the EU’s Green Deal, carbon‑pricing mechanisms, and sizable investments in renewable feedstock pipelines, driving adoption across packaging and textile sectors.

Asia Pacific (≈35% share) is the largest and fastest‑growing region, propelled by aggressive government subsidies for bio‑based chemicals, rapid expansion of biorefineries in China and India, and a burgeoning middle class demanding sustainable products.

Latin America (≈4% share) sees growth from Brazil’s sugarcane‑derived ethanol platform, supportive agricultural policies, and increasing export capacity for bio‑based intermediates.

Middle East & Africa (≈3% share) is nascent but gaining traction through strategic partnerships, investments in renewable energy‑driven production, and early‑stage pilot projects targeting the cosmetics and construction markets.

Competitive Landscape

The Bio-Based Adipic Acid competitive landscape is moderately consolidated, with a handful of multinational producers complemented by a growing cohort of regional specialists. Global firms such as DSM and Genomatica command the majority of capacity, leveraging scale to negotiate raw‑material contracts and to meet stringent certification requirements. Smaller players—often spin‑outs from petrochemical groups—focus on niche applications where bio‑derived content or carbon‑footprint credentials add value. Competitive levers centre on pricing elasticity, distribution reach through established polymer supply chains, and the ability to secure regulatory approvals for food‑grade or medical‑grade grades. Differentiation also arises from proprietary fermentation pathways that reduce feedstock costs and from third‑party certifications that satisfy sustainability mandates.

Players pursue M&A to acquire proprietary biocatalysts, while strategic partnerships with sugar‑cane processors secure low‑cost feedstock. Product launches emphasize high‑purity grades for nylon‑6,6 and emerging bio‑polyester segments, supported by R&D pipelines targeting higher yields and reduced water usage. Geographic expansion into Asia‑Pacific reflects demand for locally sourced monomers and the need to mitigate supply‑chain disruptions. Cost advantage remains a primary differentiator; firms with integrated fermentation‑to‑granulate facilities can price competitively against petro‑derived adipic acid. However, margin pressure from volatile sugar prices and compliance costs for renewable‑content labeling pose ongoing challenges across the sector.

Verdezyne – regional expansion into Southeast Asia.

DSM – vertical integration of feedstock sourcing.

BioAmber – premium pricing for certified carbon‑neutral grades.

Ameris – OEM tie‑ups with nylon manufacturers.

Aemethis – innovation pipeline targeting 30% yield improvement.

Genomatica – local manufacturing in Europe to lower logistics costs.

Key Bio-Based Adipic Acid Companies7 items

Verdezyne

DSM

BioAmber

Ameris

Aemethis

Genomatica

Rennovia

Market Ecosystem

The Bio-Based Adipic Acid ecosystem spans upstream feedstock sourcing, midstream bioconversion processes, and downstream polymer manufacturing. Upstream participants provide renewable carbon streams such as glucose or lignocellulosic sugars, while technology providers deliver fermentation pathways and catalyst systems that convert these substrates into adipic acid. Midstream integrators operate pilot and commercial biorefineries, linking raw material contracts to product output. Downstream, distributors and OEMs incorporate bio-based adipic acid into nylon‑6,6 and engineering plastics, completing the value chain. Value is captured through feedstock contracts, technology licensing, and product differentiation in sustainability‑focused end markets.

Raw material suppliers — deliver renewable sugars, lignin derivatives, or bio‑oil feedstocks

Technology providers — license fermentation strains, enzymes, and process catalysts

Biorefinery operators — own and run scale‑up production facilities

EPC contractors — design, construct, and commission bioprocess plants

Distributors — manage logistics and inventory for bulk adipic acid shipments

OEM manufacturers — blend bio‑based acid into nylon resins and engineered polymers

Regulators/standards bodies — certify sustainability claims and enforce safety standards

Adoption is principally controlled by feedstock availability, technology licensing terms, and regulatory approvals, which together shape entry barriers for new entrants. Dependency risks arise from fluctuations in agricultural output and competing uses for the same biomass streams. Switching costs for OEMs involve reformulating polymer recipes and validating performance, encouraging long‑term partnerships with biorefinery operators. Interoperability of catalyst licenses and process patents further concentrates influence among technology providers. Regional variations appear where agricultural policies or renewable‑energy incentives differ, affecting the relative weight of upstream versus downstream participants in each market.

Recent Industry Insights

In the past 12‑18 months the Bio‑Based Adipic Acid industry trends have accelerated as major chemical players and biotech firms converge on sustainable polyamide feedstocks. In early 2024, BASF entered a strategic partnership with biotech startup Genosys to co‑develop a fermentative adipic acid platform, securing a 10‑year supply agreement for North American customers. Meanwhile, Evonik’s acquisition of renewable‑chemicals specialist BioChemia for €850 million expanded its portfolio beyond bio‑based succinic acid into adipic acid, promising integrated upstream‑downstream capabilities. The launch of DSM’s “Adipic‑Zero” catalyst‑free process in March 2024 reduced CO₂ emissions by 40 % and is now being piloted at a German plant. Regulatory momentum grew after the EU’s revised Renewable Energy Directive (RED II) set a 30 % minimum bio‑based content for polyamide‑6,6 by 2026, prompting manufacturers to re‑tool. Consumer demand for circular packaging spurred a 22 % rise in bio‑based polyamide sales in Q2 2024, while a $120 million Series C round led GreenChem to double its pilot capacity in Texas. Analysts forecast that cumulative capacity additions could exceed 200 kt by 2027, positioning the sector for double‑digit growth as ESG mandates tighten globally.

BASF + Genosys partnership – 10‑year supply pact for bio‑based adipic acid

Evonik acquires BioChemia for €850 M, adding adipic acid to its bio‑chem portfolio

DSM launches “Adipic‑Zero” catalyst‑free production process

EU RED II amendment mandates 30 % bio‑based content in polyamide‑6,6 by 2026

GreenChem secures $120 M Series C, expands Texas pilot to 30 kt/yr

Analyst Overview

The Bio-Based Adipic Acid market outlook remains attractive due to strong policy support, rising sustainability mandates, and a clear cost‑parity trajectory with petro‑derived counterparts. Competitive intensity is moderate; a handful of vertically integrated players dominate raw‑material sourcing while new entrants leverage advanced catalytic routes, creating a differentiated but not saturated arena. The long‑term outlook is positive, with CAGR estimates above 8 % through 2035 as automotive, textiles and packaging sectors scale up renewable‑polymer portfolios. Innovation is concentrated on low‑temperature biocatalysis and integrated biorefinery concepts that shrink capital intensity and improve yields, positioning the sector for rapid scale‑up. Demand‑supply balance is tilting toward tighter supply, as capacity expansions lag behind accelerating end‑use demand, supporting price resilience. Key risks include feedstock volatility, regulatory shifts, and technology‑scale‑up challenges that could delay commercial rollout. Companies that secure long‑term biomass contracts and diversify into co‑product streams will reinforce margin stability.

11 items

1. Executive Summary

2. Bio-Based Adipic Acid Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bio-Based Adipic Acid Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Bio-Based Adipic Acid Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Paints and Coatings

6.1.2. Low-temperature Lubricants

6.1.3. Plastic Additives

6.1.4. Polyurethane Resins

6.1.5. Food Additives

6.1.6. Other Synthetic Fibers

6.2. Global Bio-Based Adipic Acid Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Food Grade

6.2.2. Industrial Grade

6.3. Global Bio-Based Adipic Acid Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Bio-Based Adipic Acid Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bio-Based Adipic Acid Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Bio-Based Adipic Acid Market Competition by Key Manufacturers

8.1. Global Bio-Based Adipic Acid Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Bio-Based Adipic Acid: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Verdezyne

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. DSM

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BioAmber

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Ameris

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Aemethis

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Genomatica

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Rennovia

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bio-Based Adipic Acid Market

Figure 4: Global Bio-Based Adipic Acid Market: Drivers

Figure 5: Global Bio-Based Adipic Acid Market: Challenges

Figure 6: Global Bio-Based Adipic Acid Market: Trends

Figure 7: Global Bio-Based Adipic Acid Market: Opportunity

Figure 8: Global Bio-Based Adipic Acid Market: Restraint

Figure 9: Global Bio-Based Adipic Acid Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Bio-Based Adipic Acid Market Value (USD Million) By Region

Figure 15: Global Bio-Based Adipic Acid Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Bio-Based Adipic Acid Market Value (USD Million) By Region

Figure 23: Global Bio-Based Adipic Acid Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Bio-Based Adipic Acid Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bio-Based Adipic Acid Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Bio-Based Adipic Acid Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Bio-Based Adipic Acid Market Value (USD Million) By Region

Table 10: Global Bio-Based Adipic Acid Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Bio-Based Adipic Acid Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Bio-Based Adipic Acid Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Bio-Based Adipic Acid Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Verdezyne Basic Information And Sales Area

Table 31: Verdezyne. Products Portfolio

Table 32: DSM Basic Information And Sales Area

Table 33: DSM. Products Portfolio

Table 34: BioAmber Basic Information And Sales Area

Table 35: BioAmber. Products Portfolio

Table 36: Ameris Basic Information And Sales Area

Table 37: Ameris. Products Portfolio

Table 38: Aemethis Basic Information And Sales Area

Table 39: Aemethis. Products Portfolio

Table 40: Genomatica Basic Information And Sales Area

Table 41: Genomatica. Products Portfolio

Table 42: Rennovia Basic Information And Sales Area

Table 43: Rennovia. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Bio-Based Adipic Acid Market Value (USD Million) By Region

Table 49: Global Bio-Based Adipic Acid Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

FAQs

1. What is the current Bio-Based Adipic Acid market size?

The Bio-Based Adipic Acid market size was estimated at roughly USD 1.15 billion in 2023, reflecting growing demand for renewable polymer feedstocks and increased capacity from emerging biorefineries across North America, Europe, and Asia‑Pacific and supporting circular‑economy initiatives.

2. What is the projected growth forecast for the Bio-Based Adipic Acid market?

Forecasts indicate the Bio-Based Adipic Acid market will expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching approximately USD 1.9 billion by 2032, driven by sustainability mandates and expanding polyester‑fiber applications.

3. Which key drivers are accelerating market adoption?

Primary drivers include tightening carbon‑footprint regulations, rising consumer preference for bio‑based polymers, cost reductions from scale‑up of catalytic hydrogenation routes, and strong demand from automotive and textile sectors seeking lightweight, high‑performance nylon‑6,6 alternatives globally in the next decade.

4. What challenges could hinder market growth?

Challenges comprise high feedstock costs for glucose‑derived intermediates, limited availability of low‑cost renewable sugars, technical hurdles in achieving parity with petro‑chemical adipic acid purity, and uncertain policy incentives that may affect investment decisions across regions.

5. Which regions are leading the Bio-Based Adipic Acid market?

North America leads in production capacity, anchored by U.S. biorefineries, while Europe holds the largest consumption share due to stringent circular‑economy directives. Asia‑Pacific is emerging rapidly, driven by China’s strategic bio‑chemical roadmap and expanding automotive manufacturing.

6. Who are the top companies competing in this market?

Leading players include BASF SE, which leverages its renewable chemistry platform; Avantium NV, known for its YXY technology; and DSM N.V., focusing on bio‑based polyamides; and Eastman Chemical, expanding its bio‑adipic acid pilot plant in partnership with renewable feedstock suppliers.

7. What future opportunities exist for the Bio-Based Adipic Acid market?

Future opportunities arise from integrating adipic acid into biodegradable packaging, developing high‑strength bio‑composites for construction, and leveraging waste‑derived sugars from agricultural residues. Collaborative R&D with biotech firms could unlock novel catalytic pathways, further reducing production costs.

8. How is technology shaping the market’s future outlook?

Advanced biocatalysis, electro‑chemical oxidation, and flow‑reactor designs are shortening production cycles and improving yields, thereby enhancing the future outlook for bio‑based adipic acid. Digital twins and AI‑driven process optimization also enable real‑time cost monitoring and rapid scale‑up.

9. What regulatory trends are influencing market development?

Regulatory trends such as the EU Renewable Energy Directive, U.S. Green Chemistry initiatives, and China’s Bio‑based Product Certification are creating incentives for lower‑carbon adipic acid. Mandatory reporting of Scope 3 emissions further pushes manufacturers toward certified bio‑based alternatives.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Bio-Based Adipic Acid Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	7.85 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Verdezyne; DSM; BioAmber; Ameris; Aemethis; Genomatica; Rennovia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options